58
Views
0
CrossRef citations to date
0
Altmetric
Review

Widespread Pain in Temporomandibular Disorders

, &
Pages 181-187 | Published online: 02 Mar 2011

Bibliography

  • Macfarlane GJ : Generalized pain, fibromyalgia and regional pain: an epidemiological view.Baillieres Best Pract. Res. Clin. Rheumatol.13 , 403–414 (1999).
  • Turp JC , KowalskiCJ, O‘LearyN, StohlerCS: Pain maps from facial pain patients indicate a broad pain geography.J. Dent. Res.77 , 1465–1472 (1998).
  • Cieza A , StuckiG, WeiglM et al.: ICF core sets for chronic widespread pain.J. Rehabil. Med.63–68 (2004).
  • Croft P , RigbyAS, BoswellR, SchollumJ, SilmanA: The prevalence of chronic widespread pain in the general population.J. Rheumatol.20 , 710–713 (1993).
  • Bergman S : Psychosocial aspects of chronic widespread pain and fibromyalgia.Disabil. Rehabil.27 , 675–683 (2005).
  • Jones GT , SilmanAJ, PowerC, MacfarlaneGJ: Are common symptoms in childhood associated with chronic widespread body pain in adulthood? Results from the 1958 British Birth Cohort Study.Arthritis Rheum.56 , 1669–1675 (2007).
  • Jones GT , SilmanAJ, MacfarlaneGJ: Predicting the onset of widespread body pain among children.Arthritis Rheum.48 , 2615–2621 (2003).
  • Macfarlane GJ , McBethJ, SilmanAJ: Widespread body pain and mortality: prospective population based study.BMJ323 , 662–665 (2001).
  • Maixner W : Temporomandibular joint disorders. In: Functional Pain Syndromes: Presentation and Pathophysiology. Mayer EA, Bushnell MC (Eds). IASP Press, Seattle, WA, USA (2009).
  • Bergman S , HerrstromP, JacobssonLT, PeterssonIF: Chronic widespread pain: a three year followup of pain distribution and risk factors.J. Rheumatol.29 , 818–825 (2002).
  • McBeth J , MacfarlaneGJ, BenjaminS, SilmanAJ: Features of somatization predict the onset of chronic widespread pain: results of a large population-based study.Arthritis Rheum.44 , 940–946 (2001).
  • Gupta A , SilmanAJ, RayD et al.: The role of psychosocial factors in predicting the onset of chronic widespread pain: results from a prospective population-based study.Rheumatology (Oxford)46 , 666–671 (2007).
  • Smith BH , MacfarlaneGJ, TorranceN: Epidemiology of chronic pain, from the laboratory to the bus stop: time to add understanding of biological mechanisms to the study of risk factors in population-based research?Pain127 , 5–10 (2007).
  • Von Korff M , LeRescheL, DworkinS: First onset of common pain symptoms: a prospective study of depression as a risk factor.Pain55 , 251–258 (1993).
  • Carnes D , ParsonsS, AshbyD et al.: Chronic musculoskeletal pain rarely presents in a single body site: results from a UK population study.Rheumatology (Oxford)46 , 1168–1170 (2007).
  • Von Korff M , DworkinSF, Le Resche L, Kruger A: An epidemiologic comparison of pain complaints. Pain32 , 173–183 (1988).
  • Grossi ML , GoldbergMB, LockerD, TenenbaumHC: Irritable bowel syndrome patients versus responding and nonresponding temporomandibular disorder patients: a neuropsychologic profile comparative study.Int. J. Prosthodont.21 , 201–209 (2008).
  • Diatchenko L , NackleyAG, SladeGD, FillingimRB, MaixnerW: Idiopathic pain disorders – pathways of vulnerability.Pain123 , 226–230 (2006).
  • Macfarlane TV , GrayRJM, KinceyJ, WorthingtonHV: Factors associated with the temporomandibular disorder, pain dysfunction syndrome (PDS): Manchester case-control study.Oral Dis.7 , 321–330 (2001).
  • Korszun A , PapadopoulosE, DemitrackM, EnglebergC, CroffordL: The relationship between temporomandibular disorders and stress-associated syndromes.Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.86 , 416–420 (1998).
  • Aaron LA , BurkeMM, BuchwaldD: Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder.Arch. Intern. Med.160 , 221–227 (2000).
  • Diatchenko L , SladeGD, NackleyAG et al.: Genetic basis for individual variations in pain perception and the development of a chronic pain condition.Hum. Mol. Genet.14 , 135–143 (2005).
  • Yunus MB : Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness.Semin. Arthritis Rheum.37 , 339–352 (2008).
  • The American Academy of Orofacial Pain: Orofacial Pain. Guidelines for Assessment, Diagnosis, and Management. de Leeuw R (Ed.). Quintessence Publishing Co. Inc., Hanover Park, IL, USA (2008).
  • Balasubramaniam R , de Leeuw R, Zhu H, Nickerson RB, Okeson JP, Carlson CR: Prevalence of temporomandibular disorders in fibromyalgia and failed back syndrome patients: a blinded prospective comparison study. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.104 , 204–216 (2007).
  • Zolnoun DA , RohlJ, MooreCG, Perinetti-LiebertC, LamvuGM, MaixnerW: Overlap between orofacial pain and vulvar vestibulitis syndrome.Clin. J. Pain24 , 187–191 (2008).
  • Wiesinger B , MalkerH, EnglundE, WanmanA: Back pain in relation to musculoskeletal disorders in the jaw-face: a matched case-control study.Pain131 , 311–319 (2007).
  • Lim PF , SmithS, BhalangK, SladeGD, MaixnerW: Development of temporomandibular disorders is associated with greater bodily pain experience.Clin. J. Pain26 , 116–120 (2010).
  • Marklund S , WiesingerB, WanmanA: Reciprocal influence on the incidence of symptoms in trigeminally and spinally innervated areas.Eur. J. Pain14 , 366–371 (2010).
  • Wiesinger B , MalkerH, EnglundE, WanmanA: Does a dose–response relation exist between spinal pain and temporomandibular disorders?BMC Musculoskelet. Disord.10 , 28 (2009).
  • Aggarwal VR , MacfarlaneGJ, FarragherTM, McBethJ: Risk factors for onset of chronic oro-facial pain – results of the North Cheshire oro-facial pain prospective population study.Pain149 , 354–359 (2010).
  • Raphael KG , MarbachJJ, KlausnerJ: Myofascial face pain. Clinical characteristics of those with regional vs. widespread pain.J. Am. Dent. Assoc.131 , 161–171 (2000).
  • Wolfe F , SmytheHA, YunusMB et al.: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee.Arthritis Rheum.33 , 160–172 (1990).
  • Wolfe F : The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic.Ann. Rheum. Dis.56 , 268–271 (1997).
  • Wolfe F , ClauwDJ, FitzcharlesMA et al.: The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity.Arthritis Care Res. (Hoboken)62 , 600–610 (2010).
  • Coster L , KendallS, GerdleB, HenrikssonC, HenrikssonKG, BengtssonA: Chronic widespread musculoskeletal pain – a comparison of those who meet criteria for fibromyalgia and those who do not.Eur. J. Pain12 , 600–610 (2008).
  • Wolfe F , KatzRS, MichaudK: Jaw pain: its prevalence and meaning in patients with rheumatoid arthritis, osteoarthritis, and fibromyalgia.J. Rheumatol.32 , 2421–2428 (2005)
  • Leblebici B , PektasZO, OrtancilO, HurcanEC, BagisS, AkmanMN: Coexistence of fibromyalgia, temporomandibular disorder, and masticatory myofascial pain syndromes.Rheumatol. Int.27 , 541–544 (2007).
  • Pennacchio EA , Borg-SteinJ, KeithDA: The incidence of pain in the muscles of mastication in patients with fibromyalgia.J. Mass Dent. Soc.47 , 8–12 (1998).
  • Gatchel RJ , GarofaloJP, EllisE, HoltC: Major psychological disorders in acute and chronic TMD: an initial examination.J. Am. Dent. Assoc.127 , 1365–1370 (1996).
  • Vierck CJ Jr: Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia). Pain124 , 242–263 (2006).
  • Vierck CJ Jr, Cannon RL, Fry G, Maixner W, Whitsel BL: Characteristics of temporal summation of second pain sensations elicited by brief contact of glabrous skin by a preheated thermode. J. Neurophysiol.78 , 992–1002 (1997).
  • Staud R , RobinsonME, PriceDD: Temporal summation of second pain and its maintenance are useful for characterizing widespread central sensitization of fibromyalgia patients.J. Pain8 , 893–901 (2007).
  • Sarlani E , GreenspanJD: Why look in the brain for answers to temporomandibular disorder pain?Cells Tissues Organs180 , 69–75 (2005).
  • King CD , WongF, CurrieT, MauderliAP, FillingimRB, RileyJL 3rd: Deficiency in endogenous modulation of prolonged heat pain in patients with irritable bowel syndrome and temporomandibular disorder. Pain143 , 172–178 (2009).
  • de Souza JB , PotvinS, GoffauxP, CharestJ, MarchandS: The deficit of pain inhibition in fibromyalgia is more pronounced in patients with comorbid depressive symptoms.Clin. J. Pain25 , 123–127 (2009).
  • Desmeules JA , CedraschiC, RapitiE et al.: Neurophysiologic evidence for a central sensitization in patients with fibromyalgia.Arthritis Rheum.48 , 1420–1429 (2003).
  • Perrot S , JavierRM, MartyM, Le Jeunne C, Laroche F: Is there any evidence to support the use of anti-depressants in painful rheumatological conditions? Systematic review of pharmacological and clinical studies. Rheumatology (Oxford)47 , 1117–1123 (2008).
  • McQuay HJ , CarrollD, GlynnCJ: Dose-response for analgesic effect of amitriptyline in chronic pain.Anaesthesia48 , 281–285 (1993).
  • Giske L , VollestadNK, MengshoelAM, JensenJ, KnardahlS, RoeC: Attenuated adrenergic responses to exercise in women with fibromyalgia – a controlled study.Eur. J. Pain12 , 351–360 (2008).
  • Martinez-Lavin M : Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia.Arthritis Res. Ther.9(4) , 216 (2007).
  • Light KC , BragdonEE, GrewenKM, BrownleyKA, GirdlerSS, MaixnerW: Adrenergic dysregulation and pain with and without acute β-blockade in women with fibromyalgia and temporomandibular disorder.J. Pain10 , 542–552 (2009).
  • Houghton LA , FellC, WhorwellPJ, JonesI, SudworthDP, GaleJD: Effect of a second-generation α2δ ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome.Gut56 , 1218–1225 (2007).
  • McBeth J , ChiuYH, SilmanAJ et al.: Hypothalamic–pituitary–adrenal stress axis function and the relationship with chronic widespread pain and its antecedents.Arthritis Res. Ther.7 , R992–R1000 (2005).
  • Uceyler N , ValenzaR, StockM, SchedelR, SprotteG, SommerC: Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain.Arthritis Rheum.54 , 2656–2664 (2006).
  • Diatchenko L , AndersonAD, SladeGD et al.: Three major haplotypes of the β2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder.Am. J. Med. Genet. B Neuropsychiatr. Genet.141B(5) , 449–462 (2006).
  • Hocking LJ , SmithBH, JonesGT, ReidDM, StrachanDP, MacfarlaneGJ: Genetic variation in the β2-adrenergic receptor but not catecholamine-O-methyltransferase predisposes to chronic pain: results from the 1958 British Birth Cohort Study.Pain149(1) , 143–151 (2010), Erratum in 150(1) , 210 (2010).
  • Diatchenko L , NackleyAG, TchivilevaIE, ShabalinaSA, MaixnerW: Genetic architecture of human pain perception.Trends Genet.23(12) , 605–613 (2007).
  • Foulkes T , WoodJN: Pain genes.PLoS Genet.4(7) , e1000086 (2008).
  • Tremblay J , HametP: Genetics of pain, opioids, and opioid responsiveness.Metabolism59(Suppl. 1) , S5–S8 (2010).
  • Croft P , DunnKM, Von Korff M: Chronic pain syndromes: you can‘t have one without another. Pain131 , 237–238 (2007).
  • Aggarwal VR , McBethJ, ZakrzewskaJM, LuntM, MacfarlaneGJ: The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors?Int. J. Epidemiol.35 , 468–476 (2006).
  • Kadam UT , ThomasE, CroftPR: Is chronic widespread pain a predictor of all-cause morbidity? A 3 year prospective population based study in family practice.J. Rheumatol.32 , 1341–1348 (2005).
  • Davies KA , MacfarlaneGJ, NichollBI et al.: Restorative sleep predicts the resolution of chronic widespread pain: results from the EPIFUND study.Rheumatology (Oxford)47 , 1809–1813 (2008).
  • Perrot S , BouhassiraD, FermanianJ: Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST).Pain150 , 250–256 (2010).
  • Lipton RB , DodickD, SadovskyR et al.: A self-administered screener for migraine in primary care: the ID Migraine validation study.Neurology61 , 375–382 (2003).
  • Lowe B , WahlI, RoseM et al.: A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population.J. Affect Disord.122 , 86–95 (2010).
  • Kroenke K , SpitzerRL, WilliamsJB: The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms.Psychosom. Med.64 , 258–266 (2002).
  • Violani C , DevotoA, LucidiF, LombardoC, RussoPM: Validity of a short insomnia questionnaire: the SDQ.Brain Res. Bull.63 , 415–421 (2004).
  • Hadzi-Pavlovic D , HickieIB, WilsonAJ, DavenportTA, LloydAR, WakefieldD: Screening for prolonged fatigue syndromes: validation of the SOFA scale.Soc. Psychiatry Psychiatr. Epidemiol.35 , 471–479 (2000).
  • Gupta A , McBethJ, MacfarlaneGJ et al.: Pressure pain thresholds and tender point counts as predictors of new chronic widespread pain in somatising subjects.Ann. Rheum. Dis.66 , 517–521 (2007).
  • Fernandez-de-las-Penas C , Galan-del-RioF, Ortega-SantiagoR, Jimenez-GarciaR, Arendt-NielsenL, SvenssonP: Bilateral thermal hyperalgesia in trigeminal and extra-trigeminal regions in patients with myofascial temporomandibular disorders.Exp. Brain Res.202 , 171–179 (2010).
  • Kroner-Herwig B : Chronic pain syndromes and their treatment by psychological interventions.Curr. Opin. Psychiatry22 , 200–204 (2009).
  • Raffa RB : Pharmacology of oral combination analgesics: rational therapy for pain.J. Clin. Pharm. Ther.26 , 257–264 (2001).
  • Kroenke K , KrebsEE, BairMJ: Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews.Gen. Hosp. Psychiatry31 , 206–219 (2009).
  • Ito M , KimuraH, YoshidaK, KimuraY, OzakiN, KuritaK: Effectiveness of milnacipran for the treatment of chronic pain in the orofacial region.Clin. Neuropharmacol.33 , 79–83 (2010).
  • Kyle JA , DuganBD, TestermanKK: Milnacipran for treatment of fibromyalgia.Ann Pharmacother.44 , 1422–1429 (2010).
  • Wright CL , MistSD, RossRL, JonesKD: Duloxetine for the treatment of fibromyalgia.Expert Rev. Clin. Immunol.6 , 745–756 (2010).
  • Tchivileva IE , LimPF, SmithSB et al.: Effect of catechol-O-methyltransferase polymorphism on response to propranolol therapy in chronic musculoskeletal pain: a randomized, double-blind, placebo-controlled, crossover pilot study.Pharmacogenet. Genomics20 , 239–248 (2010).
  • Lotsch J , GeisslingerG, TegederI: Genetic modulation of the pharmacological treatment of pain.Pharmacol. Ther.124 , 168–184 (2009).
  • Younger J , MackeyS: Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study.Pain Med.10 , 663–672 (2009).
  • Pogatzki-Zahn EM , EnglbrechtJS, SchugSA: Acute pain management in patients with fibromyalgia and other diffuse chronic pain syndromes.Curr. Opin. Anaesthesiol.22 , 627–633 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.